“Because of the BOLD Act, public health departments have been making a real-world impact in their communities by implementing effective Alzheimer’s interventions, such as increasing early detection and diagnosis and reducing risk,” said Robert Egge, AIM president and Alzheimer’s Association chief public policy officer. “On behalf of the Alzheimer’s and dementia community, thank you to HELP Committee Chair Bernie Sanders, Ranking Member Bill Cassidy, lead sponsors Sens. Susan Collins, Catherine Cortez Masto, Shelley Moore Capito, and Tim Kaine, and the committee members for supporting the BOLD Reauthorization Act today to continue this great progress being made.”

“Through BOLD, for the first time, we put real resources behind the interventions that can help improve the health and quality of life for people living with Alzheimer’s and their caregivers, as well as to reduce the costs associated with this disease…Reauthorizing the BOLD Act will allow this work to continue,” said Sen. Susan Collins (R-Maine).

“It was a pleasure to work on the original version of this bill in 2018. It’s done an awful lot of good,” said Sen. Tim Kaine (D-Va.). “I think I’m like everyone on this committee with a direct connection to Alzheimer’s. The build out of this public health infrastructure to tackle the challenge is a very laudatory and very bipartisan priority.”

“If you think about Alzheimer’s, it’s the etiology, the treatment and the management. And [the BOLD Reauthorization Act] is along the lines of the management,” said Sen. Bill Cassidy (R-La.). “I think somebody in the future will look back and say to us, ‘How do you address Alzheimer’s?’ And I wish that we have the same victory on Alzheimer’s as we have with syphilis, tuberculosis and almost cancer. But I don’t want it to be 60 years. I want it to be 10, and this bill helps make it 10.”

This bipartisan legislation will reauthorize the BOLD Act and empower public health departments to continue improving brain health and supporting caregivers in their communities. In February, the BOLD Reauthorization Act was introduced in the Senate. A companion bill was introduced in the House in February, and since introduction, dedicated AIM advocates have been urging their members of Congress to support this bipartisan legislation, resulting in 80 cosponsors in the House and 31 in the Senate. In March, the BOLD Reauthorization Act unanimously passed the House Energy and Commerce Committee.
 

About the Alzheimer’s Association

The Alzheimer’s Association is a worldwide voluntary health organization dedicated to Alzheimer’s care, support and research. Our mission is to lead the way to end Alzheimer’s and all other dementia — by accelerating global research, driving risk reduction and early detection, and maximizing quality care and support. Our vision is a world without Alzheimer’s and all other dementia®. Visit alz.org or call 800.272.3900.

Alzheimer’s Impact Movement

The Alzheimer’s Impact Movement (AIM) is a separately incorporated advocacy affiliate of the Alzheimer’s Association. AIM works to develop and advance policies to overcome Alzheimer’s disease through increased investment in research, enhanced care and improved support. For more information, visit alzimpact.org.